arrow
M

Michele Bottosso

university of padova
H指数:13
被引数:882

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Patterns of central nervous system and leptomeningeal involvement in advanced breast cancer with invasive lobular histology: a large multicenter study with a focus on estrogen receptor-positive/HER2-negative disease

浸润性小叶组织学特征的晚期乳腺癌中枢神经系统和软脑膜受累模式:一项针对雌激素受体阳性/HER2阴性疾病的的多中心大型研究

2026-10-210
OAAI
Basal-like HR + /HER2- breast cancers show higher tumor-infiltrating lymphocytes and immune signatures with potential therapeutic implications

Basal-like HR⁺/HER2⁻乳腺癌显示出更高的肿瘤浸润淋巴细胞和免疫特征,具有潜在的治疗意义。

2025-12-240
OAAI
PIK3CA mutations and first-line outcomes in endocrine-resistant HR+/HER2- metastatic breast cancer: a multicentric real-world study.

PIK3CA突变和内分泌抵抗性HR+/HER2-转移性乳腺癌的一线治疗效果:一项多中心真实世界研究。

2025-12-190
PREAI
Real-world outcomes of early-stage HER2-positive breast cancer patients treated with adjuvant paclitaxel and trastuzumab

HER2阳性早期乳腺癌患者接受辅助紫杉醇和曲妥珠单抗治疗的真实世界结局

2025-11-260
OAAI
Gene expression profiling in a retrospective real-world cohort of breast cancer brain metastases and paired primary tumors identifies biological changes with potential therapeutic implications

乳腺癌脑转移瘤及其配对原发肿瘤的回顾性真实世界队列基因表达谱分析,识别出具有潜在治疗意义生物学变化

2025-07-230
PREAI
Impact of germline BRCA1/2 status on outcomes for patients with HR+/HER2- metastatic breast cancer treated with CDK4/6 inhibitors: a systematic review and meta-analysis

胚系BRCA1/2状态对接受CDK4/6抑制剂治疗的HR+/HER2-转移性乳腺癌患者结局的影响:一项系统评价和荟萃分析

2025-07-220
OAAI
HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndrome (vol 211, 114307, 2024)

HER2状态和乳腺癌患者及Li-Fraumeni综合征患者对新辅助抗HER2治疗的反应(卷211,114307,2024)

2025-05-010
PRE
Temporal evolution of breast cancer brain metastases treatments and outcomes
2025-02-200
OA
Clinical applications of radiomics and deep learning in breast and lung cancer: A narrative literature review on current evidence and future perspectives

放射组学和深度学习在乳腺癌和肺癌中的临床应用: 关于当前证据和未来前景的叙述性文献综述

2024-11-012
OAAI
A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+Breast Cancer

基于残余癌负荷和肿瘤浸润淋巴细胞对HER2乳腺癌新辅助治疗后残余病变的预后模型

2023-07-074
OAAI
Radiological response of leptomeningeal metastases according to revised RANO criteria is associated with overall survival in breast cancer patients

根据修订的RANO标准,软脑膜转移的放射学反应与乳腺癌患者的总生存率相关

2023-05-272
OAAI